Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were gastrointestinal and headaches. The study was supported by the National Institute of Neurological Disorders and… Continue reading Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage
Tag: MS
On the Horizon: Treatment to Block Progression of Multiple Sclerosis
A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM, and they have shown that blocking this molecule could delay the onset of the disease and… Continue reading On the Horizon: Treatment to Block Progression of Multiple Sclerosis
Chemical Compound Decreases Effects of Multiple Sclerosis
A team of researchers led by biomedical scientist Seema K. Tiwari-Woodruff, an associate professor at the University of California, Riverside School of Medicine has identified a drug called indazole chloride (Ind-Cl) that could stimulate “remyelination,” the re-sheathing of the axons, restoring fast and uninterrupted flow of nerve impulses for patients with multiple sclerosis (MS). This… Continue reading Chemical Compound Decreases Effects of Multiple Sclerosis